Advances in the management of subependymal giant cell astrocytoma

Keyphrases

• Subependymal Giant Cell Astrocytoma 100%
• Tuberous Sclerosis Complex 60%
• Ventriculomegaly 40%
• Clinical Trials 40%
• Treatment Options 20%
• Hydrocephalus 20%
• Response Rate 20%
• Protein Kinase 20%
• Mammalian Target of Rapamycin (mTOR) 20%
• Surgical Management 20%
• Medical Therapy 20%
• Medical Management 20%
• Surgical Resection 20%
• Gross Total Resection 20%
• Neuroimaging 20%
• Central Nervous System Tumors 20%
• Tuberous Sclerosis 20%
• MTOR Inhibitor 20%
• Everolimus 20%
• Sudden Death 20%
• Obstructive Hydrocephalus 20%
• Foramen of Monro 20%
• Variable Response 20%
• Gamma Knife Radiosurgery 20%

Medicine and Dentistry

• Subependymal Giant Cell Astrocytoma 100%
• Tuberous Sclerosis 80%
• Clinical Trial 40%
• Ventriculomegaly 40%
• Stereotactic Radiosurgery 20%
• Central Nervous System Tumor 20%
• Mechanistic Target of Rapamycin 20%
• Mammalian Target of Rapamycin Inhibitor 20%
• Hydrocephalus 20%
• Protein Kinases 20%
• Everolimus 20%
• Sudden Death 20%
• Obstructive Hydrocephalus 20%
• Surgical Procedure 20%
• Treatment Option 20%

Neuroscience

• Astrocytoma 100%
• Tuberous Sclerosis 80%
• Hydrocephalus 40%
• Mammalian Target of Rapamycin 40%
• Central Nervous System 20%
• Protein Kinases 20%
• Everolimus 20%
• Nervous System Tumor 20%